# Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study

> **NCT00002037** · NA · COMPLETED · sponsor: **Amgen** · enrollment: 15 (—)

## Conditions studied

- Mycobacterium Avium-Intracellulare Infection
- HIV Infections

## Interventions

- **DRUG:** Trifluridine

## Key facts

- **NCT ID:** NCT00002037
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 15 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002037, "Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*